NNP
ELV icon

Nachman Norwood & Parrott’s Elevance Health ELV Stock Holding History

Nachman Norwood & Parrott’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-238
Closed -$64K – 484
2020
Q3 		$64K Buy
+238
New +$64K 0.01% 396

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nachman Norwood & Parrott's ELV Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Elevance Health (ELV) in Q4 2020, closing a stake of 238 shares — an estimated $64K sold.

Nachman Norwood & Parrott first reported a position in ELV in Q3 2020 and held it in 1 quarter. The position peaked at $64K in Q3 2020. 1,170 funds tracked by Wall St. Rank hold ELV as of Q4 2020.

  • Nachman Norwood & Parrott reported no remaining Elevance Health position as of Q4 2020 after selling out during the quarter.
  • Nachman Norwood & Parrott sold 238 Elevance Health shares in Q4 2020, an estimated $64K.
  • Nachman Norwood & Parrott first reported a position in Elevance Health in Q3 2020 and held it in 1 quarter.
  • Nachman Norwood & Parrott's Elevance Health position peaked at $64K in Q3 2020.
  • 1,170 funds tracked by Wall St. Rank held Elevance Health as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.